Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Regional Nasal Block vs Dexmedetomidine in Endoscopic Sinus Surgery
NCT05361642Unknown
- Sponsor
- Ain Shams University
- Start
- Feb 2022
- Primary completion
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of bupivacaine and dexmedetomidine in sinusitis (2 arms), sponsored by Ain Shams University. Primary endpoint: Optimizing intraoperative surgical field up to 6 months. Status: unknown.
02
Drugs
bupivacainedexmedetomidine
03
Conditions
sinusitis
Beyond the preview
Go deeper on NCT05361642.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05361642.